With over 30% of diabetes patients at risk of developing diabetic retinopathy, early detection is critical for prevention.

In a strategic move to enhance efficiency, Avant plans to establish a standalone company dedicated to developing diabetes treatments.

The global AI in healthcare market is projected to surpass $110 billion by 2030, with a remarkable annual growth rate of 38.6%, indicating a rapid transformation in medical practices.

AI is anticipated to unlock an additional $461 billion in value for the healthcare sector by 2035, as the industry approaches a total valuation of $2.26 trillion.

AI's role in healthcare is increasingly recognized, with the U.S. Department of Justice utilizing AI tools to aid in a significant crackdown on healthcare fraud.

Microsoft is collaborating with cancer diagnostics firm Lunit to enhance AI-driven healthcare solutions, focusing on improving diagnostic accuracy and operational efficiency.

In a significant expansion, Astrana Health, Inc. has acquired Prospect Health for $708 million, enhancing its AI-powered healthcare services and integrated care platform.

Palantir Technologies has partnered with TeleTracking to improve healthcare operations through AI, aiming to streamline hospital functions and enhance patient care.

The World Health Organization's AI for Health initiative aims to provide strategic guidance and promote ethical standards to advance global health goals.

The WHO is hosting a workshop on July 11, 2025, to discuss the transformative role of AI in healthcare, emphasizing responsible use and innovation.

Avant Technologies, Inc. is nearing a significant regulatory milestone with the U.S. FDA for its Vision AI disease-screening platform, which focuses on improving the detection of diabetic retinopathy and related systemic conditions.

To promote early detection and intervention for diabetes-related conditions, Avant has started offering free Vision AI scans at pharmacy chains.